RE:Some news finally!Unfortunately it's crappy news....they are canning the current study, which we have all been waiting for UFB... August as a meeting date only ...long term Covid???? This will go on for at least another 2 years to assess any clinical outcomes...more income $$ in McCrappity's pocket. "Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."